Paid Clinical Trials New Haven
Discover 1,063 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
Thrombectomy PlatformStrokeNet Thrombectomy Endovascular Platform
Sponsor:
Medical University of South Carolina
Location:
Code:
NCT06289985
Conditions
Ischemic Stroke
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Endovascular thrombectomy with any FDA-approved category POL or NRY device
Medical Management
BI 1703880 & EzabenlimabA Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT05471856
Conditions
Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BI 1703880
Ezabenlimab
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Nutrition InterventionFood for Thought - a Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Location:
Code:
NCT06582615
Conditions
Anatomic Stage II Breast Cancer AJCC V8
Anatomic Stage III Breast Cancer AJCC V8
Triple-Negative Breast Carcinoma
Eligibility Criteria
Sex: Female
Age: 40 - 65
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Cognitive Assessment
Dietary Intervention
Medical Device Usage and Evaluation
Questionnaire Administration
VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Sponsor:
Bayer
Location:
Code:
NCT04142437
Conditions
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
larotrectinib(Vitrakvi, BAY2757556)
AnifrolumabA 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
Sponsor:
AstraZeneca
Location:
Code:
NCT06015737
Conditions
Cutaneous Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Anifrolumab
Placebo
Digital WellnessAssessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
Sponsor:
Yale University
Location:
Code:
NCT05810259
Conditions
Wellness
Quality of Life
Anxiety
Depression
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
Caravan Wellness app
InebilizumabThe ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Sponsor:
University of Utah
Location:
Code:
NCT04372615
Conditions
Autoimmune Encephalitis
Encephalitis
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Inebilizumab
Placebo